Kolexia
Lemare Francois Pharmacien
Lemare Francois
Pharmacien
Clcc Hopital Gustave Roussy
Chevilly-Larue, France
116 Activités
3 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Tumeurs hématologiques Maladie chronique Métastase tumorale Nausée Leucémie aigüe myéloïde Lymphomes Adénocarcinome pulmonaire Adénocarcinome

Collaborateurs

Voir plus
Annereau Maxime
Annereau Maxime
Gustave-Roussy, Villejuif, France
Minvielle Etienne
Minvielle Etienne
Gustave-Roussy, Villejuif, France
Di Palma Mario
Di Palma Mario
Gustave-Roussy, Villejuif, France
Desmaris Romain
Desmaris Romain
Clcc Institut Curie, Paris, France

Industries

Voir plus
Pfizer
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
2161P Organization of hospital pharmaceutical consultations for cancer patients receiving oral anticancer drugs: A nationwide cross-sectional study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients.
Pharmaceuticals (Basel, Switzerland)   29 avril 2022
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial.
Nature medicine   25 avril 2022
5-Azacitidine in patients with IDH1/2-mutant recurrent glioma.
Neuro-oncology   06 avril 2021
335MO Intervention combining nurse navigators (NNs) and a mobile application vs standard of care (SOC) in neuro-oncology patients (pts) treated with oral anticancer agents (OAA): A subgroup analysis of CAPRI, a single-center, randomized phase III trial
Abstract Book of the ESMO Asia Virtual Congress 2020 20-22 November 2020   01 novembre 2020
Organization of chemotherapeutic preparations in advance: Do we save or waste money?
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   27 octobre 2020
Intervention combining nurse navigators (NNs) and a mobile application versus standard of care (SOC) in cancer patients (pts) treated with oral anticancer agents (OAA): Results of CapRI, a single-center, randomized phase III trial.
2020 ASCO Annual Meeting I   25 mai 2020
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II result.
European journal of haematology   28 janvier 2020
Audit de bonnes pratiques du traitement des escarres en oncologie
Le Pharmacien Hospitalier et Clinicien   01 mars 2019
Development and stability of an oral suspension of procarbazine in pediatrics
Journal of drug delivery science and technology   01 février 2019